Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
Tags:
FDA, breakthrough therapies, AbbVie, Alexion, Ariad Pharmaceuticals, Biomarin, Bristol-Myers Squibb, SynaGeva BioPharma, GSK, JNJ, Merck, Novartis, Pharmacyclics, Pfizer, Vertex Pharmaceuticals, daratumumab, ibrutinib, Kalydeco, lambrolizumab, palbociclib, LDK378, SD-101, obinutuzumab, serelaxin, asfotase alfa, bimagrumab, drisapersen, sebelipase alfa
Abbott should not be liable for additional Depakote damages, says Wells Fargo
Yahoo/Fly on the Wall
Mon, 08/19/13 - 09:42 am
Tags:
Abbott Labs, Depakote, AbbVie
2 Drug Companies to Buy and 1 to Sell
Motley Fool
Sat, 08/17/13 - 11:22 am
Tags:
Sanofi, Gilead Sciences, AbbVie
The 5 Best-Selling Medications of 2013 (So Far)
Motley Fool
Tue, 08/6/13 - 11:24 am
Tags:
AbbVie, Humira, Advair, GSK, Seretide, Enbrel, Amgen, Pfizer, Lantus, Sanofi, Avastin, Roche
Abbott Labs: Balancing Growth and Profits
Yahoo/TheStreet.com
Mon, 08/5/13 - 07:25 am
Tags:
AbbVie, Abbott Labs
Wall Street Happy To Hum La AbbVie En Rose
Investopedia
Sat, 07/27/13 - 11:05 am
Tags:
AbbVie
AbbVie profit beats forecasts, Humira sales strong
Reuters
Fri, 07/26/13 - 09:01 am
Tags:
AbbVie, earnings
Will AbbVie Earnings Stay Healthy?
Motley Fool
Thu, 07/25/13 - 09:51 am
Tags:
AbbVie, earnings
FDA advisory panel votes against new use of AbbVie's Humira
Reuters
Wed, 07/24/13 - 09:51 am
Tags:
FDA, advisory panels, AbbVie, Humira, spondyloarthritis
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Sat, 07/20/13 - 11:26 am
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, Bristol-Myers Squibb, Idenix
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
Tags:
hepatitis C, AbbVie, Bristol-Myers Squibb, Gilead, Idenix, sofosbuvir, ledipasvir, daclatasvir, asunaprevir, BMS-791325, IDX20963
Abbott's Winning (Baby) Formula for Success. Are There More Spinoffs to Come? Comment Now Follow Comments
Forbes
Wed, 07/17/13 - 12:33 pm
Tags:
Abbott Laboratories, spinoffs, AbbVie, nutrition, infant nutrition
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Sat, 07/13/13 - 12:31 pm
Tags:
Pharmacyclics, ibrutinib, blood cancer, JNJ, AbbVie
Achillion May Be The Most Underrated Biotech Left
Seeking Alpha
Wed, 06/26/13 - 09:35 am
Tags:
Achillion, AbbVie, Bristol-Myers Squibb, Gilead, Vertex Pharmaceuticals, Indenix, ACH-3102, ACH-1625, hepatitis C
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Tue, 06/18/13 - 08:54 am
Tags:
Humira, AbbVie, Galapagos, GLPG0634, Chron's Disease, Incyte, Eli Lilly, Pfizer, rheumatoid arthritis
AbbVie announces preliminary results in Phase 1 study of ABT-199
Yahoo/Fly on the Wall
Mon, 06/17/13 - 09:23 am
Tags:
AbbVie, ABT-199, chronic lymphocytic leukemia
AbbVie says it could beat Gilead to huge market for hep C drugs
Fierce Pharma
Fri, 06/14/13 - 10:34 am
Tags:
AbbVie, Gilead, hepatitis C
Is Concentration Better Than Diversification in Pharma?
Motley Fool
Thu, 06/13/13 - 12:01 pm
Tags:
diversification, concentration, AbbVie, Abbott Labs, Pfizer, Zoetis, spinoffs
New Data Improves Sales Outlook For Celgene's Apremilast
TheStreet.com
Wed, 06/12/13 - 08:52 am
Tags:
Celgene, apremilast, JNJ, Amgen, AbbVie, psoriatic arthritis
Abbott Doubled Niaspan U.S. Sales Before Trials Cut Use
Bloomberg
Mon, 06/10/13 - 07:59 pm
Tags:
Abbott Laboratories, Niaspan, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.